Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study

Gustav Andersson, Signe Borgquist, Karin Jirström, Gustav Andersson, Signe Borgquist, Karin Jirström

Abstract

The incidence of pancreatic cancer is leveling between sexes. Smoking, high age and heredity are established risk factors, but evidence regarding the influence of hormonal factors is unclear. In this study, we investigated the associations of reproductive factors, use of oral contraceptives (OC) and hormone replacement therapy (HRT) with pancreatic cancer risk in the Malmö Diet and Cancer Study, a prospective, population-based cohort encompassing 17,035 women. Up until 31 December 2015, 110 women were identified with incident pancreatic cancer through the Swedish Cancer Registry. Higher age at menarche was significantly associated with pancreatic cancer risk (age-adjusted [hazard ratio] HR = 1.17; 95% confidence interval [CI] 1.04-1.32, and fully adjusted HR = 1.17; 95% CI 1.04-1.32). Ever use of OC was not significantly associated with pancreatic cancer risk but ever use of HRT was significantly associated with a decreased risk of pancreatic cancer (age-adjusted HR = 0.47, 95% CI 0.23-0.97, and fully adjusted HR = 0.48, 95% CI 0.23-1.00), in particular use of estrogen-only regimen (age-adjusted HR = 0.21; 95% CI 0.05-0.87 and fully adjusted HR = 0.22; 95% CI 0.05-0.90). Age at menopause or first childbirth, parity and breastfeeding history were not significantly associated with pancreatic cancer risk. Collectively, these findings suggest a protective role of female hormones against pancreatic cancer. Further studies are needed, and potential modifying genetic factors and indirect hazardous effects of smoking should also be considered.

Keywords: hormone replacement therapy; oral contraceptives; pancreatic cancer risk; reproductive factors.

© 2018 The Authors International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Figures

Figure 1
Figure 1
Flowchart of the cohort.

References

    1. World Health Organization . World Cancer Report 2014.
    1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
    1. The Board of National Health and Welfare . Statistics on Cancer Incidence 2015.
    1. Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet 2004;363:1049–57.
    1. Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996;156:2255–60.
    1. Silverman DT, Dunn JA, Hoover RN, et al. Cigarette smoking and pancreas cancer: a case‐control study based on direct interviews. J Natl Cancer Inst 1994;86:1510–6.
    1. Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet 2011;378:607–20.
    1. Yeo TP, Hruban RH, Leach SD, et al. Pancreatic cancer. Curr Probl Cancer 2002;26:176–275.
    1. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640–4.
    1. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first‐degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738–44.
    1. Bosetti C, Rosato V, Li D, et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case‐Control Consortium. Ann Oncol 2014;25:2065–72.
    1. Elena JW, Steplowski E, Yu K, et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 2013;24:13–25.
    1. Larsson SC, Permert J, Hakansson N, et al. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population‐based cohorts. Br J Cancer 2005;93:1310–5.
    1. Raimondi S, Lowenfels AB, Morselli‐Labate AM, et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010;24:349–58.
    1. Duell EJ, Lucenteforte E, Olson SH, et al. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case‐Control Consortium (PanC4). Ann Oncol 2012;23:2964–70.
    1. Bracci PM, Wang F, Hassan MM, et al. Pancreatitis and pancreatic cancer in two large pooled case‐control studies. Cancer Causes Control 2009;20:1723–31.
    1. Gapstur SM, Jacobs EJ, Deka A, et al. Association of alcohol intake with pancreatic cancer mortality in never smokers. Arch Intern Med 2011;171:444–51.
    1. Lucenteforte E, La Vecchia C, Silverman D, et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case‐Control Consortium (PanC4). Ann Oncol 2012;23:374–82.
    1. Gupta S, Wang F, Holly EA, et al. Risk of pancreatic cancer by alcohol dose, duration, and pattern of consumption, including binge drinking: a population‐based study. Cancer Causes Control 2010;21:1047–59.
    1. Jiao L, Silverman DT, Schairer C, et al. Alcohol use and risk of pancreatic cancer: the NIH‐AARP Diet and Health Study. Am J Epidemiol 2009;169:1043–51.
    1. Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010;170:791–802.
    1. Michaud DS, Giovannucci E, Willett WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. Jama 2001;286:921–9.
    1. Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 2011;129:1708–17.
    1. Fernandez E, La Vecchia C, D'Avanzo B, et al. Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer 1995;62:11–4.
    1. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, et al. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population‐based case‐control study in The Netherlands. Int J Cancer 1992;52:24–9.
    1. Lin Y, Kikuchi S, Tamakoshi A, et al. Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Gastroenterol 2006;41:878–83.
    1. Prizment AE, Anderson KE, Hong CP, et al. Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study. JOP 2007;8:16–27.
    1. Duell EJ, Holly EA. Reproductive and menstrual risk factors for pancreatic cancer: a population‐based study of San Francisco Bay Area women. Am J Epidemiol 2005;161:741–7.
    1. Lee E, Horn‐Ross PL, Rull RP, et al. Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol 2013;178:1403–13.
    1. Stevens RJ, Roddam AW, Green J, Million Women Study C , et al. Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2009;18:1457–60.,.
    1. Duell EJ, Travier N, Lujan‐Barroso L, et al. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int J Cancer 2013;132:2164–75.
    1. Skinner HG, Michaud DS, Colditz GA, et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 2003;12:433–8.
    1. Teras LR, Patel AV, Rodriguez C, et al. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control 2005;16:1035–40.
    1. Heuch I, Jacobsen BK, Albrektsen G, et al. Reproductive factors and pancreatic cancer risk: a Norwegian cohort study. Br J Cancer 2008;98:189–93.
    1. Kreiger N, Lacroix J, Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol 2001;11:563–7.
    1. Lucenteforte E, Zucchetto A, Bosetti C, et al. Reproductive and hormonal factors and pancreatic cancer risk in women. Pancreas 2011;40:460–3.
    1. Zhang Y, Coogan PF, Palmer JR, et al. A case‐control study of reproductive factors, female hormone use, and risk of pancreatic cancer. Cancer Causes Control 2010;21:473–8.
    1. Ji BT, Hatch MC, Chow WH, et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case‐control study in Shanghai, China. Int J Cancer 1996;66:432–7., Jr.,
    1. Karlson BM, Wuu J, Hsieh CC, et al. Parity and the risk of pancreatic cancer: a nested case‐control study. Int J Cancer 1998;77:224–7.
    1. Manjer J, Carlsson S, Elmstahl S, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non‐participants. Eur J Cancer Prev 2001;10:489–99.
    1. Korn EL, Graubard BI, Midthune D. Time‐to‐event analysis of longitudinal follow‐up of a survey: choice of the time‐scale. Am J Epidemiol 1997;145:72–80.
    1. Andersson G, Wennersten C, Borgquist S, et al. Pancreatic cancer risk in relation to sex, lifestyle factors, and pre‐diagnostic anthropometry in the Malmo Diet and Cancer Study. Biol Sex Differ 2016;7:66
    1. Boron WF, Boulpaep EL. Medical physiology, 2nd ed. Saunders, Elsevier, 2012.
    1. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114–7.
    1. Duell EJ, Maisonneuve P, Baghurst PA, et al. Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC. Cancer Causes Control 2009;20:1757–62.
    1. Bourhis J, Lacaine F, Augusti M, et al. Protective effect of oestrogen in pancreatic cancer. Lancet 1987;2:977
    1. Devesa SS, Silverman DT. Protective effect of oestrogen in pancreatic cancer. Lancet 1988;2:905–6.
    1. Ruan X, Mueck AO. Impact of smoking on estrogenic efficacy. Climacteric 2015;18:38–46.
    1. Gu F, Caporaso NE, Schairer C, et al. Urinary concentrations of estrogens and estrogen metabolites and smoking in Caucasian women. Cancer Epidemiol Biomarkers Prev 2013;22:58–68.
    1. Key TJ, Pike MC, Brown JB, et al. Cigarette smoking and urinary oestrogen excretion in premenopausal and post‐menopausal women. Br J Cancer 1996;74:1313–6.
    1. Sandberg AA, Kirdani RY, Varkarakis MJ, et al. Estrogen receptor protein of pancreas. Steroids 1973;22:259–71.
    1. Sandberg AA, Rosenthal HE. Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem 1979;11:293–9.
    1. Greenway B, Iqbal MJ, Johnson PJ, et al. Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J (Clin Res Ed) 1981;283:751–3.
    1. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113–24.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel